Literature DB >> 2547257

Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment.

E Dussaix1, C Wood.   

Abstract

From November 1985 to August 1987, 22 children underwent orthotopic liver transplantation (OLT). Primary cytomegalovirus (CMV) infection was observed in 3 of 10 seronegative recipients (30%). It was severe in 2 cases, which were treated successfully by a combination of DHPG and CMV hyperimmune globulin. From September 1987 to August 1988, a virologic survey was undertaken. It enabled us to take prophylactic measures and to make an early diagnosis of CMV infection, permitting early antiviral treatment. During this period, 26 children received liver grafts. Nine of 13 seronegative recipients (69, 2%) developed primary CMV infection. Seven had received immunoprophylaxis and 8 were treated by DHPG. None had severe disease and all improved rapidly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547257

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  Antimicrobial strategies in the care of organ transplant recipients.

Authors:  R H Rubin; N E Tolkoff-Rubin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  OKT3 and viral disease in pediatric liver transplant recipients.

Authors:  James S Bowman; Michael Green; Velma P Scantlebury; Saturo Todo; Andreas Tzakis; Shunzaburo Iwatsuki; Laura Douglas; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-08       Impact factor: 2.863

4.  Prospective cytomegalovirus surveillance in paediatric renal transplant patients.

Authors:  S Iragorri; D Pillay; M Scrine; R S Trompeter; L Rees; P D Griffiths
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

5.  Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.

Authors:  C Lumbreras; J R Otero; J A Herrero; R Gomez; M Lizasoain; J M Aguado; F Colina; I Garcia; E Moreno; A R Noriega
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 6.  Cytomegalovirus infection and disease after liver transplantation. An overview.

Authors:  R J Stratta; M S Shaeffer; R S Markin; R P Wood; A N Langnas; E C Reed; J P Donovan; G L Woods; K A Bradshaw; T J Pillen
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.